INTELLIGENT BIO SOLUTIONS INC. Income Statement
INBS|5 years of annual SEC 10-K data (FY2021-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
INTELLIGENT BIO SOLUTIONS INC. reported $3M in revenue and $10M in net loss for FY2025. Revenue has grown at a 101.5% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -3.36 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.1M | $1.3M | $1.3M | $2.0M | $188.7K |
| Cost of Revenue | $1.7M | $930.2K | $930.2K | - | - |
| Gross Profit | $1.4M | $326.7K | $326.7K | - | - |
| SG&A Expense | $9.3M | $8.0M | $4.9M | $3.4M | $2.2M |
| Operating Income | -$10.3M | -$12.6M | -$8.3M | -$5.6M | -$2.9M |
| Net Income | -$10.2M | -$10.6M | -$8.3M | -$7.0M | -$3.2M |
| EPS (Basic) | -$6.38 | -$127.00 | -$11.33 | -$0.68 | - |
| EPS (Diluted) | -$6.38 | -$127.00 | -$11.33 | - | -$0.37 |
| Shares Outstanding | 3.5M | 194.2K | 2.3M | 13.6M | 8.6M |
| Gross Margin | 45.8% | 26.0% | 26.0% | - | - |
| Operating Margin | -330.5% | -1002.1% | -663.3% | -281.4% | -1513.7% |
| Profit Margin | -326.4% | -845.9% | -660.9% | -355.3% | -1676.2% |